Company Overview and News

 
Niti Aayog, ABB join hands to benefit India from AI, robotics

2018-05-23 livemint
New Delhi: ABB India and Niti Aayog on Wednesday inked a pact to help the country reap the benefits of latest technologies including robotics and artificial intelligence.

 
ABB India Q1 profit rises 14% to Rs 102 crore

2018-05-08 moneycontrol
ABB India today posted 13.9 per cent rise in profit to Rs 102.49 crore for the first quarter ended March of 2017-18. The company had posted a profit of Rs 89.98 crore in the year-ago period.

 
ABB India Limited - Outcome of Board Meeting

2018-05-08 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
ABB India Limited - Press Release

2018-05-08 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
ABB India Limited - Financial Result Updates

2018-05-08 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
ABB India Limited - Updates

2018-05-08 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
ABB, Mahindra Holidays results on Tuesday

2018-05-07 thehindubusinessline
Over two dozen companies including ABB India, AB Capital, Automotive Axles, Blue Dart Express, De Nora, Godrej Consumer, GTL Infra, HEG, Hindustan Composites, India Nippon, Jubilant Foodworks, Kajaria Ceramics, Huhtamaki PPL, Mahindra Holidays, Phoenix Mills, SKF India, Sun Pharma Advanced, Sadbhav Infrastructure, Sanofi India, Sintex Industries, Whirlpool of India and Vesuvius will declare their fourth quarter and annual results for the period ended March 2018 on Tuesday.

 
ABB India Limited - Press Release

2018-04-26 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
ABB India Limited - Press Release

2018-04-17 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

1
Srinivasan Venkatakrishnan appointed CEO of Vedanta Resources    

2018-04-16 freepressjournal.in
New Delhi: Mining mogul Anil Agarwal-led Vedanta Resources plc today announced the appointment of Srinivasan Venkatakrishnan as the new chief executive of the company, replacing interim CEO Kuldip Kaura. Venkatakrishnan, or Venkat as he is known, is currently the CEO of Johannesburg-based AngloGold Ashanti Ltd, the world’s largest emerging market gold producer. Venkat, 53, will assume the new role effective August 31, the company said in a statement.

 
ABB India Limited - Trading Window

2018-04-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
News Live: Attorney General KK Venugopal questions maintainability of petitions in PNB fraud case

2018-04-09 moneycontrol
PNB fraud case | Attorney General KK Venugopal questioned the maintainability of petitions, reports ANI. Supreme Court to now hear the matter on April 23.

 
News Live: Mood in Karnataka favours Congress, says Rahul Gandhi

2018-04-09 moneycontrol
Casualties reported in strike on Syria air base: state media A missile attack on a Syrian military airport left several dead and wounded, state media said today, after the US warned Damascus and its allies over an earlier suspected chemical attack on a rebel-held town.The strike on the Tayfur air base in the central province of Homs, came as international outrage mounts over an attack on Saturday in the rebel enclave of Eastern Ghouta.

 
ABB India Limited - Disc. under Reg.30 of SEBI (SAST) Reg.2011

2018-04-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...